Sensitization of BCL-2–expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737

Overexpression of the prosurvival protein BCL-2 is common in breast cancer. Here we have explored its role as a potential therapeutic target in this disease. BCL-2, its anti-apoptotic relatives MCL-1 and BCL-XL, and the proapoptotic BH3-only ligand BIM were found to be coexpressed at relatively high...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Oakes, Samantha R., Vaillant, François, Lim, Elgene, Lee, Lily, Breslin, Kelsey, Feleppa, Frank, Deb, Siddhartha, Ritchie, Matthew E., Takano, Elena, Ward, Teresa, Fox, Stephen B., Generali, Daniele, Smyth, Gordon K., Strasser, Andreas, Huang, David C. S., Visvader, Jane E., Lindeman, Geoffrey J.
التنسيق: Artigo
اللغة:Inglês
منشور في: National Academy of Sciences 2012
الموضوعات:
Breast Cancer Special Feature
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286989/
https://ncbi.nlm.nih.gov/pubmed/21768359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1104778108
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة